Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions
暂无分享,去创建一个
P. Matthews | D. Collins | D. Arnold | N. De Stefano | P. Matthews | DL Collins | D. L. Collins | J. Antel | S. Narayanan | L. Fu | E. Pioro | G. Francis | D. Arnold | J. Antel | N. de Stefano | J. Antel | MD D. L. Arnold | MSc S. Narayanan | MSc L. Fu | MD DPhil E. Pioro | MD N. De Stefano | PhD D. L. Collins | MD G. S. Francis | MD J. P. Antel | MD DPhil P. M. Matthews | De Pioro E | GS Francis | D. Collins
[1] M. Raichle,et al. A Stereotactic Method of Anatomical Localization for Positron Emission Tomography , 1985, Journal of computer assisted tomography.
[2] M. Mintun,et al. Enhanced Detection of Focal Brain Responses Using Intersubject Averaging and Change-Distribution Analysis of Subtracted PET Images , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[4] P T Fox. Functional brain mapping with positron emission tomography. , 1989, Seminars in neurology.
[5] Axonal dystrophy as a consequence of long-term demyelination. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[6] D. Menon,et al. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. , 1990, Journal of computer assisted tomography.
[7] E. Shoubridge,et al. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.
[8] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[9] P M Matthews,et al. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.
[10] Micheline Kamber. Automated detection of multiple sclerosis lesions in magnetic resonance images of the human brain , 1991 .
[11] W. Mcdonald,et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.
[12] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[13] J. Neale,et al. Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.
[14] Alan C. Evans,et al. MRI-PET Correlation in Three Dimensions Using a Volume-of-Interest (VOI) Atlas , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] R G Shulman,et al. Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients , 1992, Stroke.
[16] P M Matthews,et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.
[17] Alan C. Evans,et al. Anatomical mapping of functional activation in stereotactic coordinate space , 1992, NeuroImage.
[18] H. Bruhn,et al. Multiple sclerosis in children: Cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo , 1992, Annals of neurology.
[19] B. Dawson-Saunders,et al. Basic and Clinical Biostatistics , 1993 .
[20] P. M. Matthews,et al. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies , 1993, Neurology.
[21] D. Arnold,et al. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images , 1994, Annals of neurology.
[22] B. Ross,et al. Brief report: organic osmolytes in the brain of an infant with hypernatremia. , 1994, The New England journal of medicine.
[23] G. Fein,et al. Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging , 1994, Annals of neurology.
[24] G. Barker,et al. Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.
[25] W. Mcdonald. RACHELLE FISHMAN-MATTHEW MOORE LECTURE: The Pathological and Clinical Dynamics of Multiple Sclerosis , 1994, Journal of neuropathology and experimental neurology.
[26] S. Hauser. Prevention strategies for multiple sclerosis , 1994, Annals of neurology.
[27] D. Li,et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis , 1994, Annals of neurology.
[28] R I Grossman,et al. Magnetization transfer in multiple sclerosis , 1994, Annals of neurology.
[29] P. Matthews,et al. Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.
[30] P M Matthews,et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.
[31] D. L. Collins,et al. Statistics for Investigation of Multimodal MR Imaging Data and an Application to Multiple Sclerosis Patients , 1996, NMR in biomedicine.